129397-35-9

Upstream product

• 19293-62-0 p,p'-dimethoxybenzhydrylamine 
• 2043-61-0 cyclohexanecarbaldehyde 
• 5664-21-1 cyclohexylacetaldehyde 
• 5452-75-5 ethyl 2-cyclohexylacetate 
• 3289-28-9 ethyl cyclohexanecarboxylate 

Downstream Products

• 129397-42-8 isopropyl (2R*,3S*)-2-benzyloxy-4-cyclohexyl-3-(di-p-anisylmethyl)aminobutyrate 
• 129397-40-6 (3R*,4S*)-3-benzyloxy-4-cyclohexylmethyl-1-(di-p-anisylmethyl)-2-azetidinone 
• 129397-40-6 (3R,4R)-3-Benzyloxy-1-[bis-(4-methoxy-phenyl)-methyl]-4-cyclohexylmethyl-azetidin-2-one 
• 141280-91-3 (2S,3R)-2-Acetoxy-3-acetylamino-4-cyclohexyl-butyric acid isopropyl ester 
• 119642-26-1 (2R*,3S*)-cyclohexylnorstatine isopropyl ester 

Relevant academic research and scientific papers

A Stereoselective Synthesis of the (2R,3S)- and (2S,3R)-3-Amino-2-hydroxybutyric Acid Derivatives, the Key Components of a Renin Inhibitor and Bestatin

The title synthesis was achieved by featuring the -cycloaddition reaction of benzyloxyketene with a chiral imine derived from methyl (R)- or (S)-mandelate, alcoholysis of the formed 3,4-cis disubstituted β-lactam under acidic conditions, and reductiv

A NOVEL SYNTHESIS OF CYCLOHEXYLNORSTATINE ISOPROPYL ESTER, THE C-TERMINAL COMPONENT OF A RENIN INHIBITOR

The title compound was produced diastereoselectively in racemic and optically active forms by employing the cycloaddition reaction of an imine with benzyloxyketene followed by acidic alcoholysis of the formed 3,4-cis-disubstituted β-lactam with isopropanol.